Moreover, insulin resistance is a hallmark of metabolic syndrome, cancer, and CKM-related complications; dysregulation of insulin signaling contributes to diabetic cardiomyopathy, atherosclerosis, and hyperinsulinemia-driven tumorigenesis, particularly in colorectal and breast cancers [100]. This evidence concerns the gene INS and cancer.